Laboratori Fundació Dau Reig Jofre S.A.

Poland

All drugs from this manufacturer

  • GANCICLOVIR ACCORD

    The medicine is intended for the treatment of diseases caused by cytomegalovirus (CMV) in immunocompromised adults and adolescents (over 12 years of age). It is also used to prevent infections with this virus after organ transplantation or during chemotherapy in adults and children.

    Dosage form: powder for preparation of concentrate for infusion solution

    Active substance Dosage
    ganciclovir 500 mg

    ATC: J05AB06